No results for ‘’
Indrayani Biotech Ltd
₹10.85
(1.36%)
Wed, 24 Jun 2026, 07:26 pm
Consumer Services
Restaurants
24.5KIndrayani Biotech Ratios
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.77 | 0 | 23.51 | 16.21 | 21.48 | 0 |
| Price to book ratio | 0 | 0 | 4.18 | 4.20 | 4.31 | 4.40 | 4.53 | 0.62 | 0.57 | 0 | 0 | 0.10 | 1.10 | 4.32 | 3.51 | 3.33 | 0.90 |
| Price to sales ratio | 3.76 | 8.60 | 0.38 | 0.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 1.05 | 1.70 | 1.19 | 1.35 | 0.50 |
| Price to cash flow ratio | 0 | 0 | 17.02 | 10.89 | 223.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0.63 | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 0.86Cr | 1.71Cr | 16.76Cr | 15.41Cr | 14.84Cr | 14.9Cr | 14.99Cr | 2.31Cr | 2.19Cr | 2.69Cr | 3.19Cr | 15.38Cr | 36.95Cr | 122Cr | 255Cr | 345Cr | 229Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 18.66 | 20.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.53 | 0 | 18 | 14.75 | 14.58 | 35.51 |
| Debt to equity ratio | 0 | 0 | 0.62 | 0.53 | 0.04 | 0.04 | 0.08 | 0.13 | 0.16 | 0 | 0 | 0.45 | 0.79 | 0.78 | 1.30 | 1.67 | 1.89 |
| Return on equity % | 0 | 0 | -3.12 | -1.84 | -0.18 | -2.06 | -3.06 | -4.05 | -7.84 | -10.24 | 0 | 5.35 | -117.94 | 20.23 | 30.11 | 17.04 | -8.74 |
Indrayani Biotech Ltd Ratios
The Indrayani Biotech Ltd Ratios page provides a complete fundamental analysis of Indrayani Biotech Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Indrayani Biotech Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Indrayani Biotech Ltd (NSE: , BSE: 526445) is currently trading at ₹10.85, with a market capitalization of ₹48.31Cr. As a major player in the Consumer services sector and Restaurants industry, Indrayani Biotech Ltd remains a key stock for fundamental analysis using Indrayani Biotech Ltd Ratios.
Indrayani Biotech Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Indrayani Biotech Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Indrayani Biotech Ltd Ratios.
Historically, the Indrayani Biotech Ltd P/E ratio has shown strong fluctuations:
- 2024: 0
- 2023: 21.48
- 2022: 16.21
- 2021: 23.51
- 2020: 0
The decline in Indrayani Biotech Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Indrayani Biotech Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.90.
Historical P/B trend:
- 2024: 0.90
- 2023: 3.33
- 2022: 3.51
- 2021: 4.32
Indrayani Biotech Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Indrayani Biotech Ltd P/S ratio currently stands at 0.50, an important part of Indrayani Biotech Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 0.50
- 2023: 1.35
- 2022: 1.19
- 2021: 1.70
A stable or declining Indrayani Biotech Ltd P/S ratio indicates cautious market sentiment.
Indrayani Biotech Ltd Price to Cash Flow Ratio (P/CF)
The Indrayani Biotech Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.
Historical Indrayani Biotech Ltd Price to Cash Flow Ratio:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0
- 2020: 0
The declining Indrayani Biotech Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Indrayani Biotech Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Indrayani Biotech Ltd EV currently stands at ₹229Cr, representing the total company valuation including debt.
Historical EV trend:
- 2024: 229Cr
- 2023: 345Cr
- 2022: 255Cr
- 2021: 122Cr
Indrayani Biotech Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Indrayani Biotech Ltd EV/EBITDA ratio is currently 35.51, a key metric in Indrayani Biotech Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 35.51
- 2023: 14.58
- 2022: 14.75
- 2021: 18
Higher Indrayani Biotech Ltd EV/EBITDA suggests premium valuation.
Indrayani Biotech Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Indrayani Biotech Ltd D/E ratio is currently 1.89, reflecting leverage and financial stability.
Historical D/E:
- 2024: 1.89
- 2023: 1.67
- 2022: 1.30
- 2021: 0.78
Higher D/E ratio indicates rising financial risk.
Return on Equity (ROE %)
The Indrayani Biotech Ltd ROE currently stands at -8.74%, showing profitability and capital efficiency.
Historical ROE:
- 2024: -8.74
- 2023: 17.04
- 2022: 30.11
- 2021: 20.23
Declining ROE indicates pressure on profitability.
Indrayani Biotech Ltd Ratios Analysis Summary
The Indrayani Biotech Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Indrayani Biotech Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Indrayani Biotech Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.